In a report published by the American Enterprise Institute, former FDA Commissioner Scott Gottlieb proposes a road map for navigating COVID-19 in the United States.
The Centers for Medicare & Medicaid Services March 30 issued regulatory waivers and new rules to respond to the 2019 novel coronavirus pandemic.
The following is a statement from Ted Okon, executive director of the Community Oncology Alliance, on recent CMS expansions in light of COVID-19.
The Leukemia & Lymphoma Society and its partners developed the LLS COVID-19 Patient Financial Aid Program to provide $250 for eligible blood cancer patients struggling with the economic hardship because of COVID-19.
The APLICOV clinical trial protocol for Aplidin (plitidepsin) was submitted to the Spanish Medicines and Healthcare Products Agency.
A unique subgroup of patients who have COVID-19 with low severity disease experienced digestive symptoms, most notably diarrhea, according to a study published in The American Journal of Gastroenterology.
Versiti Inc. in early April plans to collect plasma from recovered COVID-19 patients to help treat others with the virus.
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage, as well as the latest meeting cancellations, is available here.
The annual meeting of the American Society of Clinical Oncology will go virtual this year, the society announced March 24.
